HSBC Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

HSBC Holdings’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,129	Closed	-$144K	–	2944
2020 Q1	$144K	Buy	20,129 +7,454	+59%	+$93K	﹤0.01%	2400
2019 Q4	$301K	Buy	+12,675	New	+$350K	﹤0.01%	2541
2017 Q1	–	Sell	-12,557	Closed	-$281K	–	2742
2016 Q4	$281K	Buy	+12,557	New	+$245K	﹤0.01%	2284

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

HSBC Holdings's PTLA Position: Q2 2020 in Review

HSBC Holdings sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 20,129 shares — an estimated $144K sold.

HSBC Holdings first reported a position in PTLA in Q4 2016 and held it in 3 quarters. The position peaked at $301K in Q4 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

HSBC Holdings reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
HSBC Holdings sold 20,129 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $144K.
HSBC Holdings first reported a position in Portola Pharmaceuticals, Inc. in Q4 2016 and held it in 3 quarters.
HSBC Holdings's Portola Pharmaceuticals, Inc. position peaked at $301K in Q4 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.